Over 1 million Triathlon Cementless Knees
implanted globally
MAHWAH,
N.J., Sept. 21, 2023 /PRNewswire/ -- Stryker
(NYSE: SYK), one of the world's leading medical technology
companies, continues its year of milestones celebration with the
10th anniversary of the Triathlon Tritanium baseplate.
Since its introduction in 2013, Triathlon Cementless, which
includes the Triathlon Tritanium Baseplate, has delivered a decade
of positive patient impact, demonstrated impressive survivorship
data and has become a trusted solution for surgeons across the
globe.
With over 1 million knees implanted to date1,
Stryker's Triathlon Cementless combines the kinematics of Triathlon
with a proprietary design and highly porous biologic fixation
technology. With its unique ability to enhance bone integration,
Triathlon Cementless has provided patients with higher
satisfaction2,3 and lower revision
rates4 compared to cemented knees. Triathlon
Cementless provides fixation and results that surgeons can
trust,1-7 supported by over 10 years of clinical use and
99% survivorship at five years.4
"Stryker has been setting the standard and leading the industry
with cementless knee procedures for a decade," said Lisa Kloes, vice president and general manager,
of Stryker's Knees business. "We are seeing a growing trend in the
adoption of Triathlon Cementless and expect those numbers to
continue to increase, especially as impressive survivorship data
continues to roll in. I'm thrilled to celebrate this milestone of
patient impact as we continue our mission to make healthcare
better."
Marking its 10th anniversary, the Triathlon
Tritanium baseplate is designed with Stryker Orthopaedic Modeling
and Analytics (SOMA) and enabled by Stryker's proprietary
additive manufacturing technology. Providing a highly porous metal
biologic fixation, this baseplate offers patients higher
satisfaction3 and hospitals improved
efficiency.2.5
As the volume of total knee arthroplasty (TKA) procedures
continues to increase, the costs associated with this surgical
procedure continues to be an important topic. Triathlon
Cementless allows for reduction of operating room time by 10-15
minutes compared to cemented knees2,5 and the
elimination of the cost and storage of bone cement and cement
accessories.6
"As a leader in additive manufacturing technologies, Stryker has
differentiated itself from the competition when it comes to
specialized medical devices, particularly with cementless
fixation," said Kloes. "Our commitment to pushing technological
boundaries in orthopaedic implant innovation sets us apart and
allows us to provide best-in-class options for our customers and
their patients."
Those living with joint pain are encouraged to speak with their
healthcare professional about available treatment plans. As a
provider, surgeons can help patients get educated on options that
may help prevent further pain and complications. To learn more
about joint health treatment options for patients, please visit
patients.stryker.com.
All surgery carries risk. Surgeons must rely on
their own professional clinical judgment when deciding whether to
utilize a particular technology when treating a patient in their
own practice. Stryker does not dispense medical advice and
recommends that surgeons be trained in the use of any technology
before using it in surgery. Not all patients will have the same
postoperative recovery and activity level. Individual results
vary.
About Stryker
Stryker is one of the world's leading medical technology companies
and, together with its customers, is driven to make healthcare
better. The company offers innovative products and services in
Medical and Surgical, Neurotechnology, Orthopaedics and Spine that
help improve patient and healthcare outcomes. Alongside its
customers around the world, Stryker impacts more than 130 million
patients annually. More information is available at
www.stryker.com.
References :
- Stryker's sales data on file
- Sharpe, K., Robinson, K., Cohen, R., Barnett TM., Rastogi, A.,
Masini, M. Does Implant Fixation Affect Early Return to Function
Following Primary Total Knee Arthroplasty. ISTA 2018. London, UK.
- Hannon CP, Salih R, Barrack RL, Nunley RM. Cementless Versus
Cemented Total Knee Arthroplasty: Concise Midterm Results of a
Prospective Randomized Controlled Trial. JBJS. 2023 Jun
22:10-2106.
- Nam D, Bhowmik-Stoker M, Mahoney OM, Dunbar MJ, Barrack RL.
Mid-Term Performance of the First Mass-Produced Three-Dimensional
Printed Cementless Tibia in the United
States as Reported in the American Joint Replacement
Registry. J Arthroplasty. 2023 Jan;38(1):85-89.
- Nam, D, et al. Cemented Versus Cementless Total Knee
Arthroplasty of the Same Modern Design: A Prospective, Randomized
Trial. The Journal of Bone and Joint Surgery 101(13):p 1185-1192,
July 3, 2019. | DOI:
10.2106/JBJS.18.01162
- Lawrie CM, Schwabe M, Pierce A, Nunley RM, Barrack RL. The cost
of implanting a cemented versus cementless total knee arthroplasty.
Bone Joint J. 2019 Jul;101-B(7_Supple_C):61-63. doi:
10.1302/0301-620X.101B7.BJJ-2018-1470.R1. PMID: 31256655.
- Triathlon Surgical Compendium TRIATH-SP-30_Rev-2_34473
View original content to download
multimedia:https://www.prnewswire.com/news-releases/strykers-triathlon-tritanium-baseplate-marks-a-decade-of-positive-patient-impact-301935368.html
SOURCE Stryker